Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Unger, E. C.
Right arrow Articles by New, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Unger, E. C.
Right arrow Articles by New, T. E.

Radiology, Vol 185, 453-456, Copyright © 1992 by Radiological Society of North America

ARTICLES

Nitrogen-filled liposomes as a vascular US contrast agent: preliminary evaluation

EC Unger, PJ Lund, DK Shen, TA Fritz, D Yellowhair and TE New
Department of Radiology/Magnetic Resonance Imaging, University of Arizona Health Sciences Center, Tucson 85724.

Liposomes with a mean diameter of 1-2 microns were made to entrap nitrogen gas and tested as an ultrasound (US) contrast agent. The gas- filled liposomes, or Aerosomes (ImaRx Pharmaceutical, Tucson) were tested in vitro for size, stability, reflectivity, and acoustic characterization, and were tested in vivo for acute toxicity in mice and for cardiac imaging in rabbits after intravenous injection. Aerosomes have much greater reflectivity and higher attenuation than do standard liposomes and retain their acoustic properties after storage in aqueous media for several months. The interpolated median lethal dose of Aerosomes is approximately 2.5 mmol of lipid per kilogram, and the imaging dose is under 5 mumol of lipid per kilogram, yielding a potential therapeutic index of over 500 to 1. Postcontrast US images showed sustained enhancement of all four cardiac chambers as well as enhancement in the aorta, vena cava, and hepatic veins. Aerosomes hold promise as a contrast agent for cardiac and blood-pool imaging. Further work is in progress to characterize and develop this novel US contrast agent.


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
A. J. Hamilton, S.-L. Huang, D. Warnick, M. Rabbat, B. Kane, A. Nagaraj, M. Klegerman, and D. D. McPherson
Intravascular ultrasound molecular imaging of atheroma components in vivo
J. Am. Coll. Cardiol., February 4, 2004; 43(3): 453 - 460.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. Hamilton, S.-L. Huang, D. Warnick, A. Stein, M. Rabbat, T. Madhav, B. Kane, A. Nagaraj, M. Klegerman, R. MacDonald, et al.
Left Ventricular Thrombus Enhancement After Intravenous Injection of Echogenic Immunoliposomes: Studies in a New Experimental Model
Circulation, June 11, 2002; 105(23): 2772 - 2778.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1992 by the Radiological Society of North America.